Smith & Nephew to buy Osiris Therapeutics in $660m deal

Osiris Therapeutics acquisition is expected to support Smith & Nephew wound management business. Credit: Smith & Nephew.



  • Smith & Nephew to buy Osiris Therapeutics in $660m deal